| Dr Rebecca Das Dores Costa, PHARMD | |
|
486 Pleasant St, Attleboro, MA 02703-2425 | |
| (508) 222-6020 | |
| Not Available |
| Full Name | Dr Rebecca Das Dores Costa |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 486 Pleasant St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467173484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH240976 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebecca Das Dores Costa, PHARMD 486 Pleasant St, Attleboro, MA 02703-2425 Ph: () - | Dr Rebecca Das Dores Costa, PHARMD 486 Pleasant St, Attleboro, MA 02703-2425 Ph: (508) 222-6020 |
News Archive
DSM Biomedical, a global leader in biomedical materials science, today announced a major step forward in the development of a new polyethylene polymer platform intended to improve the mechanical properties and long-term stability of hip and knee implants.
People with epilepsy living in high crime neighborhoods in Chicago had three times as many seizures as those living in neighborhoods with lower crime rates according to new research from the University of Illinois at Chicago presented at the American Epilepsy Society 2018 conference in New Orleans.
ADVENTRX Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 21,250,000 shares of its common stock and warrants exercisable for up to 10,625,000 additional shares at $0.80 per fixed combination of shares and warrants for gross proceeds of approximately $17 million.
Asahi Kasei Corporation, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, announced today the successful completion of its acquisition of ZOLL Medical Corporation, a major US manufacturer of medical devices for critical care, on April 26, 2012, US Eastern time.
On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.
› Verified 5 days ago
Aimee L Tague, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 196 Pleasant St, Attleboro, MA 02703 Phone: 508-222-7779 Fax: 508-222-0573 | |
Lori-ann Ucci, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 486 Pleasant St, Attleboro, MA 02703 Phone: 508-222-6020 | |
Dr. Edmond Michael Nunes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7650 Fax: 508-236-8825 | |
Abram Agayby, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 289 County St, Attleboro, MA 02703 Phone: 508-222-7620 | |
Andrew Wayland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 May St, Attleboro, MA 02703 Phone: 508-838-2293 Fax: 508-838-2294 | |
Sam Talala, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 196 Pleasant St, Attleboro, MA 02703 Phone: 508-222-7779 | |
Mr. Gerald Burnham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Sully Ln, Attleboro, MA 02703 Phone: 401-793-3040 |